TrianglePUBLICATIONS · 30980071
Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
Open original source → · Download preserved record
Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.
- Journal
- Ann Oncol
- Publication date
- 2019 Jul 1
- First author
- Shaw AT
Publication notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
Authors and identifiers
- name
- Shaw AT
- type
- Author
- name
- Riely GJ
- type
- Author
- name
- Bang YJ
- type
- Author
- name
- Kim DW
- type
- Author
- name
- Camidge DR
- type
- Author
- name
- Solomon BJ
- type
- Author
- name
- Varella-Garcia M
- type
- Author
- name
- Iafrate AJ
- type
- Author
- name
- Shapiro GI
- type
- Author
- name
- Usari T
- type
- Author
- name
- Wang SC
- type
- Author
- name
- Wilner KD
- type
- Author
Complete bibliographic record and source provenance
- authors
- name
- Shaw AT
- type
- Author
- name
- Riely GJ
- type
- Author
- name
- Bang YJ
- type
- Author
- name
- Kim DW
- type
- Author
- name
- Camidge DR
- type
- Author
- name
- Solomon BJ
- type
- Author
- name
- Varella-Garcia M
- type
- Author
- name
- Iafrate AJ
- type
- Author
- name
- Shapiro GI
- type
- Author
- name
- Usari T
- type
- Author
- name
- Wang SC
- type
- Author
- name
- Wilner KD
- type
- Author
- bibliography ids
- nci-bib-273cf62cfc24ddfb4792b051
- book metadata
- content sha256
- 477c0d8b61b7bfe4f72e03ffb5a6d96366f43bfffb3147b498e3c0d62f58d733
- document type
- citation
- dois
- 10.1093/annonc/mdz131
- electronic publication date
- display
- Source null
- precision
- missing
- year
- Source null
- evidence scope
- bibliographic_metadata_only
- id
- pubmed:30980071
- immutable id
- pubmed:30980071@477c0d8b61b7bfe4f72e03ffb5a6d96366f43bfffb3147b498e3c0d62f58d733
- journal
- abbreviation
- Ann Oncol
- issn electronic
- 1569-8041
- issn print
- 0923-7534
- issue
- 7
- name
- Annals of oncology : official journal of the European Society for Medical Oncology
- nlm unique id
- 9007735
- pages
- 1121-1126
- volume
- 30
- languages
- eng
- notices
- absence is not clearance
- true
- has correction metadata
- false
- has expression of concern metadata
- false
- has retraction in link
- false
- pubmed marks article retracted
- false
- pubmed marks retraction notice
- false
- relationships
- outcomes validated
- false
- pmid
- 30980071
- provenance
- batch id
- e808962322f3afebc564
- provider
- NCBI PubMed ESummary
- record sha256
- 19a4d0b927b5600521fe80081087d7454cad9548679a7eac1b2a1861be7a8dc8
- response sha256
- 3d610336ca8dae92b82cdb6b3ee6cab382eb509e0349b0c68c261b042b036561
- retrieved at
- 2026-09-09T23:47:41.002093+00:00
- publication date
- display
- 2019 Jul 1
- precision
- day
- year
- 2019
- publication types
- Clinical Trial, Phase I
- Journal Article
- Multicenter Study
- Research Support, Non-U.S. Gov't
- record status
- PubMed - indexed for MEDLINE
- schema version
- 1.0
- title
- Crizotinib in ROS1-rearranged advanced non-small-cell lung cancer (NSCLC): updated results, including overall survival, from PROFILE 1001.
Preserved source evidence · Not medical advice